Connor, Clark & Lunn Investment Management Ltd. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$3,168,00095,9000.02%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q1 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders